Efepoetin Alfa

DRUG3 trials

Sponsors

PT Kalbe Genexine Biologics, Genexine, Inc.

Conditions

Anaemia Associated With Chronic Kidney DiseaseAnemia of Chronic Kidney DiseaseHealthy

Phase 1

Clinical Trial of Efepoetin Alfa in Healthy Subjects

CompletedNCT06490939

Genexine, Inc.Healthy

Start: 2024-10-29End: 2025-03-25Updated: 2025-08-21

Phase 3

A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient

CompletedNCT04155125

PT Kalbe Genexine BiologicsAnaemia Associated With Chronic Kidney Disease

Start: 2020-07-02End: 2023-06-30Updated: 2023-12-22

A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

RecruitingNCT06466785

Genexine, Inc.Anemia of Chronic Kidney Disease

Start: 2024-01-25End: 2028-03-01Target: 429Updated: 2026-05-22